Improving prevention and care for pregnant and postpartum adolescent girls and young women with HIV in Tanzania
Official title: ENding HIV Transmission to Infants by Generating Evidence to Optimize Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania (ENGAGE)
Run by Karolinska Institutet · NCT06605053 · Data updated 2026-11-12
This project will test a co-designed package of services to help pregnant and postpartum adolescent girls and young women (15–24) with HIV in Tanzania stay on treatment, keep their babies HIV-free, and remain in care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years and up |
| Sex | Women only |
| Enrollment | 222 (estimated) |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 2 sites (Dar es Salaam and 1 other locations) |
| Status | Recruiting |
| Started | October 7, 2024 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | June 29, 2025 |
| Trial ID | NCT06605053 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescent girls and young women aged 15–24 living with HIV who are pregnant or up to two years postpartum in the participating regions of Tanzania, and infants born to them for registry analyses, are ideal candidates.
✕Probably not a fit
People who have not started ART, whose ART status is not recorded, or those who are mentally or severely ill and unable to participate are unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This mixed-methods project combines a registry-based cohort analysis, qualitative interviews, and co-production workshops to optimize PMTCT care for adolescent girls and young women (AGYW) aged 15–24 with HIV. The cohort component follows AGYW who started PMTCT between 2018 and 2020 to measure appointment attendance, ART retention, viral suppression, infant HIV-free survival, and repeat pregnancy up to two years postpartum. Qualitative interviews with AGYW, healthcare providers, partners, parents, and community stakeholders will identify social and structural barriers to care. Findings will be used to co-design and pilot a package of interventions tailored to the needs and preferences of AGYW in the study regions.
Why it matters
Potential benefit: If successful, the co-produced approach could increase ART retention and viral suppression among pregnant and postpartum AGYW and reduce vertical HIV transmission to their infants.
How similar studies have gone: Related PMTCT programs combining ART support and community engagement have reduced vertical transmission in other settings, but co-produced packages specifically tailored to pregnant AGYW are relatively novel and have limited direct evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Sub-study 1 (registry-based cohort analysis): Inclusion Criteria: * Pregnant/postpartum adolescent girls and young women (AGYW) with HIV aged 15-24 years, who started PMTCT services between January 1, 2018, and December 31, 2020. * Infants born to the included AGYW during this period. Exclusion Criteria: * AGYW whose ART (Antiretroviral Therapy) status was not recorded. * Women who had not started ART. Sub-study 2 (qualitative): Inclusion Criteria: * AGYW living with HIV who are currently pregnant, previously pregnant/postpartum, and never pregnant). * HCPs (Health Care Providers) at clinics providing PMTCT services. * Spouses/partners/parents of AGYW and community stakeholders within the study setting. Exclusion criteria \- Mentally or severely ill individuals unable to participate in the study activities. Sub-study 3 (co-production) Inclusion criteria: * AGYW, HCPs, spouses/partners, parents, and community stakeholders who participated in the qualitative study II. * Research team members. Exclusion criteria: \- Mentally or severely ill individuals unable to participate in the study activities. Sub-study 4 (cluster-randomized implementation trial) Inclusion criteria: \- Pregnant AGYW living with HIV (new, previously diagnosed, and transfers) receiving vertical HIV prevention services in routine healthcare between January 1, 2026, and June 30, 2026, and followed up for at least one year until June 30, 2027. Exclusion criteria: * AGYW whose ART (Antiretroviral Therapy) status was not recorded.
Where it's running
-
Management and Development for Health
Dar es Salaam, Tanzania Recruiting -
Management and Development for Health
Kagera, Tanzania Recruiting
Study contacts
- Study coordinator: Anna E Kågesten, PhD
- Email: anna.kagesten@ki.se
- Phone: 0046707302287
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Couples problem-solving support for pregnant women with HIV and depression in Malawi
This project will try couples problem-solving therapy to reduce depression and help pregnant women with HIV stick with their PMTCT treatment and care.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.